Ilika puts Stereax in front of medical device buyers

Ilika Plc

Ilika’s Stereax solid state batteries will be represented by Cirtec Medical at MEDevice Silicon Valley on 18 and 19 November 2026.

The event is focused on medical device development, making it a relevant venue for Stereax. The audience includes engineers, R&D teams, purchasing professionals and senior decision-makers involved in bringing medical technologies to market.

Ilika is putting Stereax in front of the people who assess, design and source components for medical devices. That supports commercial visibility in a market where small size, reliability and integration matter.

Cirtec Medical’s role is also relevant. Its presence gives Stereax a route into targeted discussions with medical device companies, rather than broader or less focused investor-facing promotion.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search